RxDoctor Payments DataLook up a doctor →

Scott Young, MD

Internal Medicine · Louisville, KYNPI 1104018977

Payments from drug & device makers

$23,892in general payments, 2019–2025

Across 871 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Amgen$2K
  • AbbVie$2K
  • GSK$1K
  • Boehringer Ingelheim$1K
  • Johnson & Johnson$1K
  • plus $13K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca72$2,602
Amgen61$1,977
AbbVie(2 entities)63$1,585
GSK39$1,481
Boehringer Ingelheim52$1,457
Johnson & Johnson48$1,354
Esperion Therapeutics, Inc.63$1,329
Novartis24$1,187
Novo Nordisk36$1,177
Pfizer29$768
Lilly USA, LLC43$735
Amarin Pharma, Inc.28$685
Sanofi-aventis U.S. LLC33$616
Takeda Pharmaceuticals U.S.A., Inc.30$575
Bausch Health US, LLC53$523
Antares Pharma, Inc.31$420
Biohaven Pharmaceuticals, Inc.6$404
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$398
Biohaven Pharmaceutical Holding Company Ltd.13$376
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$372
E.r. Squibb & Sons, L.L.C.10$337
Merck16$331
Exact Sciences12$295
Otsuka America Pharmaceutical, Inc.4$266
Medtronic2$250
Optinose US, Inc.2$244
Bayer6$209
Idorsia Pharmaceuticals US Inc5$191
Axsome Therapeutics, Inc.2$189
Phathom Pharmaceuticals, Inc.7$157
Regeneron Healthcare Solutions, Inc.2$143
Tris Pharma Inc2$129
Boston Scientific1$122
Clarus Therapeutics Inc.2$122
Lexicon Pharmaceuticals, Inc.1$105
Arbor Pharmaceuticals, Inc.6$101
Mylan Specialty L.p.1$98
Azurity Pharmaceuticals, Inc.6$96
Kowa Pharmaceuticals America, Inc.5$77
Eisai Inc.5$75
Ironshore Pharmaceuticals Inc.3$40
Gilead2$33
Vistapharm, Inc.2$29
Hikma Pharmaceuticals USA2$28
Sunovion Pharmaceuticals Inc.2$24
IBSA Pharma Inc.1$21
Genentech USA, Inc.1$16
Astellas Pharma US Inc1$14
Flowonix Medical Incorporated1$14
Jazz Pharmaceuticals Inc.1$14
Eyevance Pharmaceuticals LLC1$14
Avvisto Therapeutics, LLC1$13
Abbott1$13
Supernus Pharmaceuticals, Inc.1$13
Aytu Biopharma, Inc.1$13
Mission Pharmacal Company1$12
Teva Pharmaceuticals USA, Inc.1$11
Alfasigma USA, Inc.1$11

How this compares

$23,892 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$131,181
Medicare patients
316
Services billed
1,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →